Gynecomastia Procedures Market Size, Share, Opportunities, and Trends By Type, Age Group, End-User, and Geography - Forecast from 2025 to 2030

Report CodeKSI061615893
PublishedDec, 2025

Description

Gynecomastia Procedures Market Size:

Gynecomastia Procedures Market, with a 8.73% CAGR, is anticipated to reach USD 1,219.791 million in 2030 from USD 802.774 million in 2025.

Gynecomastia Procedures Market Highlights:

  • Reducing male breast tissue: Surgeons are performing liposuction daily.
  • Expanding excision techniques: Glandular removal is gaining preference.
  • Treating above-40 patients: Older men are seeking corrective surgery.
  • Driving North America growth: Cosmetic centers are increasing procedures.
  • Offering minimally invasive options: Ultrasound-assisted lipo is reducing recovery time.
  • Boosting patient confidence: Body contouring improves self-esteem.
  • Rising in cosmetic clinics: Specialized facilities are dominating demand.

To learn more about this report, request a free sample copy

It is anticipated that the gynecomastia procedures market will expand steadily.  Gynecomastia is an abnormal growth or swelling of the breast tissue that affects men and is mostly brought on by an estrogen and testosterone imbalance. Boys and men of all ages can develop it, although middle-aged to older males and those in their early to mid-adolescence are the most likely to do so. Other potential risk factors for gynecomastia include genetic makeup, the use of certain pharmaceuticals (such as anti-androgens, anti-depressants, and so forth), excessive herbal product usage, and obesity. Gynecomastia, while mostly an aesthetic issue and not a major medical ailment, can make people uncomfortable and cause social issues, especially in boys and young men.

Gynecomastia Procedures Market Growth Drivers:

The usage of drugs like anabolic steroids and antidepressants for hormonal imbalances and obesity is the main driver of the gynecomastia procedures market growth. In addition, sedentary behaviours and poor food choices are contributing factors to the rise in gynecomastia prevalence. The introduction of less invasive treatments like liposuction and glandular tissue excision, as well as improvements in treatment alternatives, have all contributed to the growth of the gynecomastia procedures market. Since liposuction has a success rate of 85% to 95%, there is a significant demand for this surgery as a therapeutic option.

  • Increasing cases of gynecomastia

Gynecomastia incidences have increased dramatically in recent years. It is therefore commonly acknowledged to be a rather common disorder. Gynecomastia affects 50–60% of teenage boys during puberty, according to the National Library of Medicine, although the majority of instances are minor and go away on their own without any kind of therapy. Gynecomastia prevalence also varies based on the community being investigated. With aging, the prevalence tends to rise, with older males experiencing it at greater rates.

  • The dominance of the above 40 age group in the gynecomastia procedures market

The over-40 age group dominates the gynecomastia procedures market due to things like hormonal changes, the long-term consequences of risk factors, the usage of medications, the prevalence of health concerns in older people, and higher financial capacity. Men's hormones alter naturally as they age, increasing their chance of developing gynecomastia. Older people are more prone to gynecomastia due to the fall in testosterone levels and rise in body fat, which promotes the growth of breast tissue. On the other hand, the 18 to 40 age group is anticipated to have profitable development throughout the projection period. When hormonal changes are at their most intense throughout puberty, gynecomastia frequently develops.

  • Advanced minimally invasive procedure approaches

The range of available treatments for gynecomastia has been broadened due to modern minimally invasive procedural techniques such as glandular tissue removal and liposuction. These developments have raised patient satisfaction and results, which is further fueling the gynecomastia procedures market growth. Additionally, because this therapy offers less intrusive procedures, lower scarring, quicker recovery periods, and greater cosmetic results, minimally invasive treatments have grown in favor of treating gynecomastia.

Power-assisted liposuction (PAL) and ultrasound-assisted liposuction (UAL) are two examples of advanced liposuction treatments that offer higher accuracy and better outcomes. Smartlipo and VASERlipo, two laser-assisted liposuction procedures, use laser or ultrasound energy to liquefy fat cells before removal. This method can aid in skin tightening and enhance the overall shape.

  • Rising focus on physical appearance

The rising link between self-esteem and beauty will also fuel the gynecomastia procedures market expansion. A 2022 Journal of Education and Health Promotion paper found that unhealthy weight in young adults was inversely correlated with self-esteem. The American Academy of Dermatology Association also reports that elderly people undergoing cosmetic operations did not have any severe negative effects. Additionally, due to a better lifestyle, older patients had better procedural outcomes from body-contouring treatments like gynecomastia than the younger age group.

  • The excision procedure is propelling

Surgical excision is more efficient than liposuction when gynecomastia involves the expansion of glandular tissue rather than merely extra fat. Also helping to boost excision surgery's appeal are improvements in surgical methods for removing glandular tissue. With the advancement of surgical techniques, it is now possible to remove glandular tissue more successfully and with little scarring. These developments have boosted both patients' and surgeons' trust in excision surgery as a therapy option, which is further fueling the gynecomastia procedures market share.

  • Increasing cosmetic surgery centers

Cosmetic surgery centers are anticipated to have the biggest gynecomastia procedures market share due to their expertise in a range of aesthetic operations, such as those related to body contouring and breast surgery. Gynecomastia treatments are frequently carried out by surgeons in these facilities who have a great deal of experience and competence in doing so, resulting in excellent results and patient satisfaction. Additionally, several long-term patient trial data attest to the safety of patients in these facilities. According to the American Society of Plastic Surgeons, cosmetic treatments carried out outside of a hospital have a complication risk of less than 1%.

Gynecomastia Procedures Market Geographical Outlook:

  • In North America, substantial growth is anticipated in the market for gynecomastia procedures.

Advanced healthcare infrastructure, a strict regulatory framework, a focus on patient safety and treatment quality, and the presence of important companies are the drivers that propel the North American gynecomastia procedures market share. Additionally, people are more likely to pursue gynecomastia therapies due to the increased accessibility to healthcare facilities and the proportional increase in disposable income. With several specialized clinics, hospitals, and healthcare organizations offering a wide range of treatment alternatives, the North American industry is extremely competitive.

Gynecomastia Procedures Market Key Developments:

  • December 2025: The FDA issued a warning to GenderBender LLC regarding unregistered medical devices, specifically breast binders marketed for cisgender men with gynecomastia as therapeutic chest compression tools.
  • October 2025: Apyx Medical submitted a new 510(k) to FDA to expand AYON Body Contouring System labeling to include power liposuction, potentially streamlining multi-step gynecomastia procedures.
  • September 2025: Apyx Medical initiated the nationwide commercial launch of its AYON Body Contouring System, engaging key surgeons with its integrated platform for advanced aesthetic contouring procedures.
  • May 2025: Apyx Medical Corporation received FDA 510(k) clearance for the AYON Body Contouring System, which combines Renuvion helium plasma with ultrasound-assisted liposuction for advanced skin tightening during gynecomastia surgery.
  • April 2025: Apyx Medical announced peer-reviewed clinical studies demonstrating favorable outcomes for Renuvion in body contouring procedures, reinforcing evidence supporting its use in surgical contouring. 

Gynecomastia Procedures Market Scope:

Report MetricDetails
Gynecomastia Procedures Market Size in 2025USD 802.774 million
Gynecomastia Procedures Market Size in 2030USD 1,219.791 million
Growth Rate8.73%
Study Period2020 to 2030
Historical Data2020 to 2023
Base Year2024
Forecast Period2025 – 2030
Forecast Unit (Value)Million
SegmentationType, Age Group, End-User, Geography
Geographical SegmentationNorth America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Gynecomastia Procedures Market
  • Allure MedSpa
  • Pace Hospitals
  • Aura Boulder
  • Gynecomastia LA
  • Mayo Clinic
Customization ScopeFree report customization with purchase

Gynecomastia Procedures Market Segmentation:

  • By Type
    • Liposuction
    • Excision
  • By Age Group
    • 18 to 40 Years
    • Above 40 Years
  • By End-User
    • Hospitals
    • Cosmetic Surgical Centers
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Indonesia
      • Thailand
      • Others

        Frequently Asked Questions (FAQs)

        The gynecomastia procedures market is growing at a CAGR of 8.73%, expected to reach USD 1,219.791 million by 2030 from USD 802.774 million in 2025.

        Key drivers include rising gynecomastia prevalence, increased use of medications affecting hormones, sedentary lifestyles, obesity, and growing adoption of minimally invasive surgical techniques.

        Men above 40 experience hormonal changes, reduced testosterone levels, increased body fat, and long-term medication effects, leading to higher gynecomastia incidence and treatment demand.

        Advanced methods such as power-assisted, ultrasound-assisted, and laser-assisted liposuction reduce invasiveness, improve precision, shorten recovery time, and enhance patient satisfaction.

        North America benefits from advanced healthcare infrastructure, high disposable income, regulatory oversight, and widespread availability of specialized cosmetic clinics, driving procedural volumes.

        Table Of Contents

        1. EXECUTIVE SUMMARY 

        2. MARKET SNAPSHOT

        2.1. Market Overview

        2.2. Market Definition

        2.3. Scope of the Study

        2.4. Market Segmentation

        3. BUSINESS LANDSCAPE 

        3.1. Market Drivers

        3.2. Market Restraints

        3.3. Market Opportunities 

        3.4. Porter’s Five Forces Analysis

        3.5. Industry Value Chain Analysis

        3.6. Policies and Regulations 

        3.7. Strategic Recommendations 

        4. TECHNOLOGICAL OUTLOOK

        5. GYNECOMASTIA PROCEDURES MARKET BY TYPE

        5.1. Introduction

        5.2. Liposuction

        5.3. Excision

        6. GYNECOMASTIA PROCEDURES MARKET BY AGE GROUP

        6.1. Introduction

        6.2. 18 to 40 Years

        6.3. Above 40 Years

        7. GYNECOMASTIA PROCEDURES MARKET BY END-USER

        7.1. Introduction

        7.2. Hospitals

        7.3. Cosmetic Surgical Centers

        8. GYNECOMASTIA PROCEDURES MARKET BY GEOGRAPHY

        8.1. Introduction

        8.2. North America

        8.2.1. USA

        8.2.2. Canada

        8.2.3. Mexico

        8.3. South America

        8.3.1. Brazil

        8.3.2. Argentina

        8.3.3. Others

        8.4. Europe

        8.4.1. Germany

        8.4.2. France

        8.4.3. United Kingdom

        8.4.4. Spain

        8.4.5. Others

        8.5. Middle East and Africa

        8.5.1. Saudi Arabia

        8.5.2. UAE

        8.5.3. Others

        8.6. Asia Pacific

        8.6.1. China

        8.6.2. India

        8.6.3. Japan

        8.6.4. South Korea

        8.6.5. Indonesia

        8.6.6. Thailand

        8.6.7. Others

        9. COMPETITIVE ENVIRONMENT AND ANALYSIS

        9.1. Major Players and Strategy Analysis

        9.2. Market Share Analysis

        9.3. Mergers, Acquisitions, Agreements, and Collaborations

        9.4. Competitive Dashboard

        10. COMPANY PROFILES

        10.1. Allure MedSpa

        10.2. Pace Hospitals

        10.3. Aura Boulder

        10.4. Gynecomastia LA

        10.5. Mayo Clinic

        10.6. Emmett Plastic Surgery

        10.7. Pristyn Care

        10.8. Park Meadows Cosmetic Surgery

        10.9. Birmingham Specialists

        10.10. Colorado Plastic Surgery Center

        11. APPENDIX

        11.1. Currency 

        11.2. Assumptions

        11.3. Base and Forecast Years Timeline

        11.4. Key benefits for the stakeholders

        11.5. Research Methodology 

        11.6. Abbreviations 

        LIST OF FIGURES

        LIST OF TABLES

        Companies Profiled

        Allure MedSpa

        Pace Hospitals

        Aura Boulder

        Gynecomastia LA

        Mayo Clinic

        Emmett Plastic Surgery

        Pristyn Care

        Park Meadows Cosmetic Surgery

        Birmingham Specialists

        Colorado Plastic Surgery Center

        Related Reports